Media-OutReach Newswire Black Group Investment Partners with Zenzic Oasis to Advance Stem Cell Therapy for Personalised Medicine
Media-OutReach Newswire AIM Vaccine has obtained clinical approval for two heavyweight products, creating new growth points for performance
Media-OutReach Newswire The global leader in rabies vaccines, the serum-free iterative rabies vaccine of AIM Vaccine has submitted a pre-application for marketing registration
Media-OutReach Newswire Immuno Cure Biotech Presents Promising Results on Phase I Clinical Trial of a Therapeutic HIV DNA Vaccine
Media-OutReach Newswire AIM Vaccine’s heavyweight single-product mRNA RSV Vaccine obtained the clinical trial approval
Media-OutReach Newswire Policy Address by Hong Kong SAR’s Chief Executive John Lee: New Initiatives to Support High-Quality Development
Media-OutReach Newswire The bull market of innovative drug technology is booming, and the leading stock AIM Vaccine has erupted upward
Media-OutReach Newswire Elevating Cancer Care: Thomson Hospital and OncoCare Medical Malaysia Announce Strategic Alliance for Excellence in Oncology
Media-OutReach Newswire PolyU researchers and academic-led startups seize prestigious awards at HICOOL Global Entrepreneur Summit and Entrepreneurship Competition
Media-OutReach Newswire New report by the Lung Cancer Education and Advocacy for Patients highlights role of patient advocacy in providing better care for patients
Media-OutReach Newswire HKU AIDS Institute & Immuno Cure’s Collaborative Therapeutic HIV Vaccine Research Project secured HK$66.7m TRS funding from Research Grant Council
Media-OutReach Newswire Goldstream Investment Limited: Proposed Strategic Acquisition of Three High-quality Assets